Fig 2. Flow chart summarizing the most important achievements from the isolation of PF1022A to recent and future human trials.
Milestones with pharmaceutical industry in lead are shown in blue, and milestones achieved with academia in lead are shown in yellow. BK, Big Potassium; DNDi, Drugs for Neglected Diseases initiative; LAT-1, latrophilin-like receptor.